Esperion Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Esperion Therapeutics Inc
CIK #0001434868
EDGAR Form CIK 2011 - 2026
10-K [0001434868]
10-Q [0001434868]
3 [0001434868]
4 [0001434868]
5 [0001434868]
8-K [0001434868]
D [0001434868]
SC 13D [0001434868]
SC 13G [0001434868]
Form 13D/13G Filer Form 13D/13G Subject Filed
Glazer Capital LLC Esperion Therapeutics Inc [2026-06-08]
Wasatch Advisors LP Esperion Therapeutics Inc [2026-04-22]
Two SEAS Capital LP Esperion Therapeutics Inc [2025-08-13]
BlackRock Inc Esperion Therapeutics Inc [2024-11-08]
BlackRock Inc Esperion Therapeutics Inc [2024-10-22]
Millennium Management LLC Esperion Therapeutics Inc [2024-06-12]
Two SEAS Capital LP Esperion Therapeutics Inc [2023-10-05]
Millennium Management LLC Esperion Therapeutics Inc [2023-08-29]
Millennium Management LLC Esperion Therapeutics Inc [2023-08-28]
Point72 Asset Management LP Esperion Therapeutics Inc [2023-04-05]
BlackRock Inc Esperion Therapeutics Inc [2023-02-07]
Millennium Management LLC Esperion Therapeutics Inc [2023-01-20]
Point72 Asset Management LP Esperion Therapeutics Inc [2022-08-23]
CVI Investments Inc Esperion Therapeutics Inc [2021-12-10]
Deep Track Capital LP Esperion Therapeutics Inc [2021-12-09]
Sabby Management LLC Esperion Therapeutics Inc [2021-12-09]
Flynn James E Esperion Therapeutics Inc [2021-12-07]
Platinum Investment Management Ltd Esperion Therapeutics Inc [2021-02-12]
State Street Corp Esperion Therapeutics Inc [2021-02-11]
Wasatch Advisors Inc Esperion Therapeutics Inc [2020-12-03]
Marshall Wace LLP Esperion Therapeutics Inc [2020-06-15]
State Street Corp Esperion Therapeutics Inc [2019-02-14]
Vanguard Group Inc Esperion Therapeutics Inc [2019-02-11]
Partner Fund Management LP Esperion Therapeutics Inc [2018-05-14]
Boxer Capital LLC Esperion Therapeutics Inc [2018-05-11]
Meditor Group Ltd Esperion Therapeutics Inc [2017-08-21]
Boxer Capital LLC Esperion Therapeutics Inc [2017-03-23]
BlackRock Inc Esperion Therapeutics Inc [2017-01-30]
Viking Global Investors LP Esperion Therapeutics Inc [2015-06-29]
Visium Asset Management LP Esperion Therapeutics Inc [2015-03-27]
FMR LLC Esperion Therapeutics Inc [2015-02-13]
Pentwater Capital Management LP Esperion Therapeutics Inc [2015-02-13]
Domain Parters VII L P Esperion Therapeutics Inc [2014-10-30]
Pfizer Inc Esperion Therapeutics Inc [2014-02-13]
Aisling Capital II LP Esperion Therapeutics Inc [2014-02-07]
Domain Parters VII L P Esperion Therapeutics Inc [2014-02-06]
Arboretum Investment Manager II LLC Esperion Therapeutics Inc [2013-12-18]
Alta Partners VIII LP Esperion Therapeutics Inc [2013-07-11]
Longitude Capital Partners LLC Esperion Therapeutics Inc [2013-07-11]
Form 3/4/5 Subject 2011 - 2026
Esperion Therapeutics Inc
Koenig Sheldon L
Halladay Benjamin
Looker Benjamin
Hoffman Robert
Carroll J Martin
Fischer Seth H Z
Thompson John Craig
Shepard Jay
Harlow John B Jr
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Esperion Therapeutics Inc ESPR
Common Stock
2026-03-17 Sell 5,708 $2.70 15,412
Esperion Therapeutics Inc ESPR
Common Stock
2026-03-17 Sell 6,424 $2.71 17,409
Esperion Therapeutics Inc ESPR
Common Stock
2026-03-17 Sell 25,578 $2.72 69,572
Esperion Therapeutics Inc ESPR
Common Stock
2026-03-13 Grant 723,760 $0.00
Esperion Therapeutics Inc ESPR
Stock Option (right to buy) · derivative
2026-03-13 Grant 269,230 $0.00
Esperion Therapeutics Inc ESPR
Stock Option (right to buy) · derivative
2026-03-13 Grant 221,270 $0.00
Esperion Therapeutics Inc ESPR
Common Stock
2026-03-13 Grant 300,840 $0.00
Esperion Therapeutics Inc ESPR
Common Stock
2026-03-13 Grant 247,430 $0.00
Esperion Therapeutics Inc ESPR
Stock Option (right to buy) · derivative
2026-03-13 Grant 647,460 $0.00
Esperion Therapeutics Inc ESPR
Common Stock
2026-01-20 Sell 1,689 $2.88 4,864
Esperion Therapeutics Inc ESPR
Common Stock
2025-12-17 Sell 7,337 $3.67 26,927
Esperion Therapeutics Inc ESPR
Common Stock
2025-12-17 Sell 48,244 $3.67 177,055
Esperion Therapeutics Inc ESPR
Common Stock
2025-12-17 Sell 6,517 $3.67 23,917
Esperion Therapeutics Inc ESPR
Stock Option (right to buy) · derivative
2025-12-04 Grant 380,000 $0.00
Esperion Therapeutics Inc ESPR
Common Stock
2025-12-04 Grant 424,536 $0.00
Esperion Therapeutics Inc ESPR
Common Stock
2025-10-17 Sell 1,248 $2.62 3,270
Esperion Therapeutics Inc ESPR
Common Stock
2025-07-17 Sell 1,304 $1.13 1,474
Esperion Therapeutics Inc ESPR
Common Stock
2025-07-17 Sell 11 $1.12 12
Esperion Therapeutics Inc ESPR
Stock Option (right to buy) · derivative
2025-07-01 Grant 40,000 $0.00
Esperion Therapeutics Inc ESPR
Common Stock
2025-06-17 Sell 30,474 $1.11 33,826
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com